Turning a Cold CRC Tumor Hot: Part 2

In part 1 we covered the differences between “hot” and “cold” tumors. To answer the question of what is being done to help CRC patients with non-MSI tumors (the majority of CRC patients), we’ll now discuss immunotherapy concepts for these…  Read More

PACES Trial S0820 – CRC CLINICAL TRIAL UPDATE

Since the inception of Fight Colorectal Cancer (Fight CRC), we have advocated for and supported cancer research. Today kicks off the first off many blogs where I will update you on the latest clinical trials for colorectal cancer research. Learn…  Read More

Ramucirumab – A New Treatment Option

The FDA approved the use of the drug ramucirumab (brand name Cyramza®) on April 24, 2015 for patients with metastatic colorectal cancer in combination with FOLFIRI. Ramucirumab with FOLFIRI is now approved for patients whose cancer has progressed during or…  Read More

Ramucirumab Treatment

There’s news coming out of a recent clinical trial evaluating the chemotherapy drug ramucirumab (Cyramza™) and colorectal cancer patients’ response. Read more to learn about this update in treatment. Breaking research for mCRC patients Recently Eli Lilly and Company announced…  Read More

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in…  Read More